Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Under-reporting of cardiovascular events in the rofecoxib Alzheimer disease studies.

Under-reporting of cardiovascular events in the rofecoxib Alzheimer disease studies. Am Heart J. 2012 Aug; 164(2):186-93.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.